Lumbar disc herniation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1) Patients with a definite diagnosis of lumbar disc herniation and a disease duration of less than 36 months; 2) Aged between 20 and 85 years; 3) Patients agree to participate in the trial and sign the informed consent form for the clinical trial.
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1) Patients with combined lumbar spinal stenosis, lumbar spondylolisthesis of degree II or above, or a history of open lumbar spine surgery; 2) Patients with fever, systemic infection, or infection foci at or around the operation site; 3) Patients in the attack period of severe visceral diseases, those with severe hypertension, diabetes, severe osteoporosis, or coronary heart disease; 4) Patients with a bleeding tendency or coagulation dysfunction; 5) Pregnant women, patients with mental illness, dementia, malignant tumors, or intraspinal tumors; 6) Patients with an unclear localization diagnosis; 7) Patients who use other drugs or treatments that may affect the evaluation of curative effects during the research process; 8) Subjects who withdraw from the study before treatment after enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Japanese Orthopaedic Association (JOA) Low Back Pain Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Oswestry Disability Index;Visual Analog Scale (VAS) score;36 - Item Short - Form Health Survey (SF - 36);Improvement of MacNab efficacy assessment; | — |
Countries
China
Contacts
The Second People's Hospital of Zhangjiagang City